Alarice Lowe

1.5k total citations
28 papers, 549 citations indexed

About

Alarice Lowe is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Alarice Lowe has authored 28 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Alarice Lowe's work include Cancer Cells and Metastasis (8 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Genomics and Diagnostics (6 papers). Alarice Lowe is often cited by papers focused on Cancer Cells and Metastasis (8 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Genomics and Diagnostics (6 papers). Alarice Lowe collaborates with scholars based in United States, Canada and South Korea. Alarice Lowe's co-authors include Sophia K. Apple, Neda A. Moatamed, Kaitlin E. Sundling, Aman Rana, Pratik Shah, I. Peter Shintaku, Joyce F. Liu, David W. Kindelberger, William T. Barry and Courtney Doyle and has published in prestigious journals such as Journal of Clinical Oncology, Theranostics and Urology.

In The Last Decade

Alarice Lowe

25 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alarice Lowe United States 13 248 170 122 110 102 28 549
Zorka Milovanović Serbia 17 261 1.1× 119 0.7× 241 2.0× 86 0.8× 86 0.8× 55 707
Hyeyoon Chang South Korea 13 282 1.1× 92 0.5× 155 1.3× 30 0.3× 108 1.1× 28 578
Diana Montezuma Portugal 15 121 0.5× 125 0.7× 249 2.0× 43 0.4× 117 1.1× 31 582
Haoyu Ren China 12 74 0.3× 86 0.5× 104 0.9× 130 1.2× 99 1.0× 26 457
Lucheng Zhu China 16 229 0.9× 194 1.1× 277 2.3× 34 0.3× 67 0.7× 54 713
Milim Kim South Korea 11 183 0.7× 125 0.7× 94 0.8× 23 0.2× 56 0.5× 26 386
Haizhen Lu China 13 231 0.9× 128 0.8× 264 2.2× 74 0.7× 113 1.1× 47 687
Yacine Hajji France 4 117 0.5× 194 1.1× 157 1.3× 35 0.3× 88 0.9× 4 606
Yanjun Hou United States 12 269 1.1× 123 0.7× 62 0.5× 33 0.3× 64 0.6× 29 442
Stacy Moulder-Thompson United States 8 323 1.3× 237 1.4× 335 2.7× 38 0.3× 84 0.8× 9 580

Countries citing papers authored by Alarice Lowe

Since Specialization
Citations

This map shows the geographic impact of Alarice Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alarice Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alarice Lowe more than expected).

Fields of papers citing papers by Alarice Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alarice Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alarice Lowe. The network helps show where Alarice Lowe may publish in the future.

Co-authorship network of co-authors of Alarice Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of Alarice Lowe. A scholar is included among the top collaborators of Alarice Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alarice Lowe. Alarice Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Balassanian, Ronald, Natalie Banet, Güliz A. Barkan, et al.. (2024). Science, Medicine, and Cytology: an educational program of the Diversity, Equity, and Inclusion Committee of the American Society of Cytopathology. Journal of the American Society of Cytopathology. 13(4). 244–253.
3.
Hu, Yue, et al.. (2024). Implementation and reception of a semi-structured resident interview to improve equity. American Journal of Clinical Pathology. 162(Supplement_1). S34–S35.
4.
Saylor, Philip J., Keisuke Otani, Rebecca Fisher, et al.. (2024). Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer. JCO Precision Oncology. 8(8). e2300230–e2300230. 4 indexed citations
5.
Wang, Aihui, et al.. (2023). Comprehensive epithelial biomarker analysis of malignant mesothelioma: EpCAM positivity is a potential diagnostic pitfall. Cancer Cytopathology. 131(8). 507–515. 1 indexed citations
6.
Wang, Aihui, et al.. (2022). Immunofluorescent and molecular characterization of effusion tumor cells reveal cancer site‐of‐origin and disease‐driving mutations. Cancer Cytopathology. 130(10). 771–782. 3 indexed citations
7.
Kuo, Lindsay E., Justine A. Barletta, Jonathan D. Schoenfeld, et al.. (2021). NUT Carcinoma of the Thyroid: An Unusual Case with a Complete Response to Treatment. Clinical Thyroidology. 33(1). 38–47. 6 indexed citations
8.
Lim, Minji, Juhee Park, Alarice Lowe, et al.. (2020). A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC. Theranostics. 10(12). 5181–5194. 19 indexed citations
9.
Torre, Matthew, Eudocia Q. Lee, Ugonma Chukwueke, et al.. (2019). Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis. Journal of the American Society of Cytopathology. 9(1). 45–54. 14 indexed citations
10.
Lowe, Alarice. (2018). Circulating Tumor Cells. Surgical pathology clinics. 11(3). 679–686. 11 indexed citations
11.
Rana, Aman, et al.. (2018). Computational Histological Staining and Destaining of Prostate Core Biopsy RGB Images with Generative Adversarial Neural Networks. arXiv (Cornell University). 828–834. 34 indexed citations
12.
Strickland, Kyle C., Markus Eszlinger, Ralf Paschke, et al.. (2018). Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP). Endocrine Pathology. 29(1). 68–74. 16 indexed citations
13.
Strickland, Kyle C., Marina Vivero, Vickie Y. Jo, et al.. (2016). Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis. Thyroid. 26(10). 1466–1471. 83 indexed citations
14.
Vivero, Marina, Charlotte I. Wang, Vickie Y. Jo, et al.. (2016). Molecular testing of different cytologic preparations in patients with advanced lung adenocarcinoma: which yields the best results?. Journal of the American Society of Cytopathology. 6(1). 16–23. 5 indexed citations
15.
Freedman, Rachel A., William T. Barry, Ian E. Krop, et al.. (2014). A phase II study of eribulin mesylate in combination with trastuzumab and pertuzumab in patients (pts) with metastatic, human epidermal growth factor receptor 2-positive breast cancer.. Journal of Clinical Oncology. 32(15_suppl). TPS668–TPS668. 1 indexed citations
16.
Liu, Joyce F., David W. Kindelberger, Courtney Doyle, et al.. (2013). Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients. Gynecologic Oncology. 131(2). 352–356. 74 indexed citations
17.
Sahni, V. Anik, et al.. (2012). Benign Metastasizing Pleomorphic Adenoma Presenting as a Solitary Kidney Mass: Imaging Features. Urology. 80(2). e17–e18. 13 indexed citations
18.
Apple, Sophia K., et al.. (2011). The Effect of Delay in Fixation, Different Fixatives, and Duration of Fixation in Estrogen and Progesterone Receptor Results in Breast Carcinoma. American Journal of Clinical Pathology. 135(4). 592–598. 40 indexed citations
19.
Moatamed, Neda A., Gouri J. Nanjangud, Alarice Lowe, et al.. (2011). Effect of Ischemic Time, Fixation Time, and Fixative Type on HER2/neu Immunohistochemical and Fluorescence In Situ Hybridization Results in Breast Cancer. American Journal of Clinical Pathology. 136(5). 754–761. 57 indexed citations
20.
Apple, Sophia K., Alarice Lowe, P. Nagesh Rao, I. Peter Shintaku, & Neda A. Moatamed. (2009). Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer. Modern Pathology. 22(9). 1151–1159. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zorka Milovanović Breakdown of academic impact, for papers by Hyeyoon Chang Breakdown of academic impact, for papers by Diana Montezuma Breakdown of academic impact, for papers by Haoyu Ren Breakdown of academic impact, for papers by Lucheng Zhu Breakdown of academic impact, for papers by Milim Kim Breakdown of academic impact, for papers by Haizhen Lu Breakdown of academic impact, for papers by Yacine Hajji Breakdown of academic impact, for papers by Yanjun Hou Breakdown of academic impact, for papers by Stacy Moulder-Thompson
Rankless by CCL
2026